REGENERON PHARMACEUTICALS INCREGENERON PHARMACEUTICALS INCREGENERON PHARMACEUTICALS INC

REGENERON PHARMACEUTICALS INC

No trades
See on Supercharts

Price target

966.220.000.00%
The 22 analysts offering 1 year price forecasts for RGO have a max estimate of — and a min estimate of —.

Analyst rating

Based on 28 analysts giving stock ratings to RGO in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


RGO EPS for the last quarter is 10.56 CHF despite the estimation of 9.91 CHF. In the next quarter EPS is expected to reach 10.10 CHF. Track more of REGENERON PHARMACEUTICALS INC financials and stay on top of what is up with the company.
In the next quarter REGENERON PHARMACEUTICALS INC revenue is expected to reach ‪3.36 B‬ CHF. Check out REGENERON PHARMACEUTICALS INC revenue and earnings and make informed decisions.
According to analysts, RGO price target is 966.22 CHF with a max estimate of 1,105.82 CHF and a min estimate of 507.96 CHF. Check if this forecast comes true in a year, meanwhile watch REGENERON PHARMACEUTICALS INC stock price chart and keep track of the current situation with RGO news and stock market news.
We've gathered opinions of 28 analysts rating RGO stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.